Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...

A new review of Medicare data shows a marked increase for both arterial and venous thrombectomy claims for venous ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific ...

Surmodics (SRDX) announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic ...

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...

Once limited by bulky, expensive imaging tools, veterinarians now have access to innovative technologies that are ...

Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to ...

HUNTINGTON — Marshall Health Network is working together to connect our community with access to our growing network of services. The following events and screenings are planned throughout October.

From deploying silk-based biomaterials to developing immune cell therapies, a host of Indian startups are steadily shining on ...

Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...